• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘤型麻风患者在1型和2型反应期间表现出类似辅助性T细胞1的细胞因子谱,白细胞介素-10表达存在差异。

Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions.

作者信息

Sreenivasan P, Misra R S, Wilfred D, Nath I

机构信息

Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Immunology. 1998 Dec;95(4):529-36. doi: 10.1046/j.1365-2567.1998.00634.x.

DOI:10.1046/j.1365-2567.1998.00634.x
PMID:9893041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1364348/
Abstract

Some leprosy patients suffer from clinical episodes associated with tissue damage which are designated as Type 1 (reversal reaction) when localized to the lesions and Type 2 (erythema nodosum leprosum, ENL) when accompanied by systemic involvement. We had reported earlier that stable, non-reaction lepromatous leprosy subjects show T helper 2 (Th2)- and Th0- but not Th1-like responses in the peripheral blood. To further understand the development of Th-like responses during disease, 32 lepromatous patients undergoing reactions were studied using cytokine-specific reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) in peripheral blood and some skin biopsies. Of interest was the evidence of a Th1-like response with presence of interferon-gamma (IFN-gamma) and absence of interleukin-4 (IL-4) mRNA in the peripheral blood mononuclear cells (PBMC) of 85 and 64% of Type 1 and 2 reaction patients, respectively, and in all reaction sites. Whereas a Th0- was seen in some, a Th2-like response was absent. IL-12p40 mRNA was seen in 21/25 ENL and all Type 1 reaction subjects irrespective of the Th phenotype. IL-12p40 and IFN-gamma were detectable in unstimulated PBMC suggesting an in vivo priming during reactions. IL-10 was mainly associated with adherent cells and showed a differential expression in the two reactions. It was present in the PBMC of ENL but not in reversal reaction patients. Moreover, it was not detectable in the skin lesions of either type of reactions. A Th1-like cytokine profile was associated with immunopathology and persisted up to 6-7 months after the onset of reactions.

摘要

一些麻风病患者会经历与组织损伤相关的临床发作,当局限于皮损时被称为1型(逆向反应),当伴有全身受累时被称为2型(结节性红斑麻风,ENL)。我们之前报道过,稳定的、无反应的瘤型麻风病患者外周血显示出辅助性T细胞2(Th2)和Th0样反应,但无Th1样反应。为了进一步了解疾病过程中Th样反应的发展,我们对32例正在经历反应的瘤型麻风病患者进行了研究,采用细胞因子特异性逆转录-聚合酶链反应(RT-PCR)和酶联免疫吸附测定(ELISA)检测外周血及部分皮肤活检组织。有趣的是,分别在85%的1型反应患者和64%的2型反应患者的外周血单个核细胞(PBMC)以及所有反应部位,均有干扰素-γ(IFN-γ)存在且白细胞介素-4(IL-4)mRNA缺失,这证明了Th1样反应。虽然在一些患者中可见Th0样反应,但未发现Th2样反应。在21/25例ENL患者和所有1型反应患者中均检测到IL-12p40 mRNA,无论其Th表型如何。在未刺激的PBMC中可检测到IL-12p40和IFN-γ,提示反应期间存在体内致敏。IL-10主要与黏附细胞相关,且在两种反应中表现出差异表达。它存在于ENL患者的PBMC中,但在逆向反应患者中不存在。此外,在两种反应类型的皮肤损害中均未检测到。Th1样细胞因子谱与免疫病理学相关,且在反应开始后可持续6至7个月。

相似文献

1
Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions.瘤型麻风患者在1型和2型反应期间表现出类似辅助性T细胞1的细胞因子谱,白细胞介素-10表达存在差异。
Immunology. 1998 Dec;95(4):529-36. doi: 10.1046/j.1365-2567.1998.00634.x.
2
The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.抗原呈递细胞对稳定型和反应性瘤型麻风患者细胞因子谱的影响。
Immunol Lett. 2000 Dec 1;75(1):69-76. doi: 10.1016/s0165-2478(00)00271-6.
3
The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.泼尼松龙治疗对结节性红斑麻风反应患者细胞因子表达的影响。
Front Immunol. 2018 Feb 9;9:189. doi: 10.3389/fimmu.2018.00189. eCollection 2018.
4
Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.一名界线类麻风患者先后出现麻风结节性红斑和反应性逆转,病变部位细胞因子mRNA模式相似。
Br J Dermatol. 2001 Jan;144(1):175-81. doi: 10.1046/j.1365-2133.2001.03970.x.
5
Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum.有和没有麻风结节性红斑的瘤型麻风患者中白细胞介素-4表达的失调。
Lepr Rev. 2000 Dec;71 Suppl:S130-7. doi: 10.5935/0305-7518.20000084.
6
Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.麻风病患者循环T细胞的细胞因子谱反映了不加区分和极化的辅助性T细胞亚群:辅助性T细胞表型稳定,不受麻风分枝杆菌相关抗原的影响。
Immunology. 1995 Sep;86(1):97-103.
7
Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients.抗炎药物可阻断细胞因子mRNA在皮肤中的积累,并改善反应性麻风患者的临床状况。
J Invest Dermatol. 2000 Dec;115(6):935-41. doi: 10.1046/j.1523-1747.2000.00158.x.
8
Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL).麻风病中细胞因子mRNA的表达:γ-干扰素和白细胞介素-12在反应(复发反应和结节性红斑反应)中可能发挥的作用。
Scand J Immunol. 1999 Nov;50(5):541-9. doi: 10.1046/j.1365-3083.1999.00622.x.
9
Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.麻风分枝杆菌的Lsr2及其合成肽可促使瘤型麻风患者的结节性红斑中T细胞反应恢复,并促使其发生逆转反应。
Clin Vaccine Immunol. 2013 May;20(5):673-82. doi: 10.1128/CVI.00762-12. Epub 2013 Feb 27.
10
Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.麻风病的教训:II 型反应(结节性红斑)期间 TH17 细胞因子的出现正让我们了解 T 细胞的可塑性。
J Drugs Dermatol. 2012 May;11(5):626-30.

引用本文的文献

1
Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023.麻风病的分类、临床特征、流行病学及宿主免疫反应:2023年根除失败情况
Cureus. 2023 Sep 6;15(9):e44767. doi: 10.7759/cureus.44767. eCollection 2023 Sep.
2
Downmodulation of Regulatory T Cells Producing TGF-β Participates in Pathogenesis of Leprosy Reactions.产生转化生长因子-β的调节性T细胞下调参与麻风反应的发病机制。
Front Med (Lausanne). 2022 Jul 18;9:865330. doi: 10.3389/fmed.2022.865330. eCollection 2022.
3
Host-Related Laboratory Parameters for Leprosy Reactions.

本文引用的文献

1
Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy.单核细胞衍生的白细胞介素10和前列腺素E2与瘤型麻风患者体内辅助性T细胞1缺失及体外T细胞抑制相关。
Immunol Lett. 1995 Dec;48(2):123-28. doi: 10.1016/0165-2478(95)02455-7.
2
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.分枝杆菌反应性T细胞产生细胞因子的分析。未能解释瘤型麻风患者外周血T细胞对麻风分枝杆菌的特异性无反应性。
J Immunol. 1993 May 15;150(10):4641-51.
3
麻风反应的宿主相关实验室参数。
Front Med (Lausanne). 2021 Oct 22;8:694376. doi: 10.3389/fmed.2021.694376. eCollection 2021.
4
Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.结节性红斑麻风患者血清白细胞介素-6 水平升高提示其可用作生物标志物。
Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):190-198. doi: 10.25259/IJDVL_143_20.
5
Susceptibility and resistance in leprosy: Studies in the mouse model.麻风病的易感性和抗性:小鼠模型研究。
Immunol Rev. 2021 May;301(1):157-174. doi: 10.1111/imr.12960. Epub 2021 Mar 3.
6
Elevated IL-6R on CD4 T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions.CD4 T 细胞上的 IL-6R 升高可促进 T1R 麻风反应患者中由 IL-6 驱动的 Th17 细胞反应。
Sci Rep. 2020 Sep 15;10(1):15143. doi: 10.1038/s41598-020-72148-7.
7
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ.内质网应激调节麻风病中髓源性抑制细胞的免疫抑制功能,在干扰素-γ存在的情况下这种功能可被克服。
iScience. 2020 May 22;23(5):101050. doi: 10.1016/j.isci.2020.101050. Epub 2020 Apr 12.
8
The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.泼尼松龙治疗对结节性红斑麻风反应患者细胞因子表达的影响。
Front Immunol. 2018 Feb 9;9:189. doi: 10.3389/fimmu.2018.00189. eCollection 2018.
9
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.全基因组测序可区分复发性麻风病例中的复发和再感染情况。
PLoS Negl Trop Dis. 2017 Jun 15;11(6):e0005598. doi: 10.1371/journal.pntd.0005598. eCollection 2017 Jun.
10
Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.效应/记忆性T细胞、TBX21基因表达及T细胞归巢受体在界线类偏瘤型麻风患者1型反应中的作用
PLoS One. 2016 Oct 20;11(10):e0164543. doi: 10.1371/journal.pone.0164543. eCollection 2016.
Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.
人白细胞介素-10由1型辅助性(Th1)和2型辅助性(Th2)T细胞克隆产生,并抑制它们的抗原特异性增殖和细胞因子产生。
J Immunol. 1993 Jan 15;150(2):353-60.
4
Patterns of cytokine production by mycobacterium-reactive human T-cell clones.人结核分枝杆菌反应性T细胞克隆的细胞因子产生模式
Infect Immun. 1993 Jan;61(1):197-203. doi: 10.1128/iai.61.1.197-203.1993.
5
Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.白细胞介素-4与白细胞介素-10协同作用,在体内抑制细胞介导的免疫反应。
Eur J Immunol. 1993 Nov;23(11):3043-9. doi: 10.1002/eji.1830231147.
6
IL-12: initiation cytokine for cell-mediated immunity.白细胞介素-12:细胞介导免疫的起始细胞因子。
Science. 1993 Apr 23;260(5107):496-7. doi: 10.1126/science.8097337.
7
A TH1-->TH2 switch is a critical step in the etiology of HIV infection.辅助性T细胞1(TH1)向辅助性T细胞2(TH2)的转变是HIV感染病因学中的关键一步。
Immunol Today. 1993 Mar;14(3):107-11. doi: 10.1016/0167-5699(93)90208-3.
8
Th1-Th2 paradigm: insights from leprosy.Th1-Th2模式:来自麻风病的见解。
J Invest Dermatol. 1994 Jun;102(6):828-32. doi: 10.1111/1523-1747.ep12381958.
9
Role of cytokines in determining T-lymphocyte function.细胞因子在决定T淋巴细胞功能中的作用。
Curr Opin Immunol. 1994 Jun;6(3):458-66. doi: 10.1016/0952-7915(94)90128-7.
10
Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones.白细胞介素12在人辅助性T(Th)细胞分化过程中诱导产生干扰素γ(IFN-γ)的稳定启动,并在已建立的Th2细胞克隆中诱导短暂的IFN-γ产生。
J Exp Med. 1994 Apr 1;179(4):1273-83. doi: 10.1084/jem.179.4.1273.